MENU
References
Recruit
Contact Us
Japanese
About Us
R&D
Research & Development
New anti-cancer drug
Platform Technologies
Drug Discovery Research
TOPK-Inhibitor
MELK-Inhibitor
Antibody
Cancer Vaccine
Pipeline
Pipeline
Business News
IR
IR
IR News
Backnumber
Shareholder's information
IR Library
Financial Results
Securities Report
Presentaion Materials
Newsletter to Shareholders
Others
Settlement
Announce
What's New
References
Recruit
Contact Us
Japanese
Top
Investor Relations
IR News
Backnumber
April.2021-March.2022
April.2021-March.2022
22/12/2021
Announcement of the press release from QST regarding the publication of 225Ac-labeled OTSA101
1/10/2021
Poster presentation of OTSA101 research for cervical cancer at the 80th Annual Meeting of the Japanese Cancer Association
back to top